what dose of tirzepatide is best for weight loss vs Semaglutide: Which Medication Works Better? Can Tirzepatide Help You Lose

Carmot Therapeutics has revealed preliminary data from the single ascending dose (SAD) portion of its ongoing Phase 1 clinical trial for CT-996, an oral small molecule GLP-1 receptor agonist (RA) currently being evaluated in a first-in-human clinical trial in participants with obesity or overweight.CT-996 is a once-daily oral, small molecule GLP-1 receptor agonist being developed for the treatment of obesity and type 2 diabetes (T2D)

The FDA significantly increased its compliance activity surrounding advertising for compounded drugs in 2025, and recent remarks from an FDA official highlighted the agencys concerns about claims that state or imply the equivalence of compounded drugs to approved drugs.

This study investigated the neuroprotective effects of semaglutide alone and in combination with papaya fruit pulp in a streptozotocin-induced rat model of diabetic encephalopathy, with emphasis on oxidative stress, insulin signaling, neuroinflammation, amyloidogenesis, and neuronal integrity

Improving insulin sensitivity through low-glycaemic nutrition, fasting windows, resistance training, and reducing fructose and ultra-processed food can significantly reduce visceral fat and restore metabolic function

: - 4.1% of GLP-1 users received an osteoporosis diagnosis, compared with 3.2% of nonusersabout a 29% higher risk

Discover common nutrition mistakes and simple fixes